Cassava Sciences | PTIE - Crediti Commerciali

Prezzo Delle Azioni
1.61
Cambio Giornaliero
-0.05 -3.01%
Mensile
-12.02%
Annuale
2.55%
Q2 Previsione
1.69




Crediti Commerciali Cambiamento Data
Abbott USD 10.57B 171M 2025-12
Amgen USD 9.57B 1.08B 2025-12
Biogen USD 1.85B 234M 2025-09
Cara Therapeutics USD 2.24M 2.26M 2025-03
Cassava Sciences USD 120K 697K 2025-12
Eisai JPY 249.06B 25B 2025-12
Eli Lilly USD 19.46B 2.25B 2025-09
Geron USD 37.66M 1.71M 2025-09
J&J USD 21.33B 3.72B 2025-12
Merck USD 12.12B 596M 2025-09
Novartis USD 12.29B 3.3B 2025-12
Novavax USD 106.45M 72.27M 2025-12
Pfizer USD 18.12B 2.02B 2025-09
Roche Holding CHF 11.9B 460M 2025-12